Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Paclitaxel|DRUG: Vinorelbine|DRUG: Herceptin|DRUG: Filgrastim
Sponsor: University of Washington
Collaborators: Amgen|Bristol-Myers Squibb|GlaxoSmithKline